Cellectar Biosciences Stock Analysis

Cellectar Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectar Biosciences recorded a loss per share of 1.4. The entity last dividend was issued on the 17th of July 2018. The firm had 1:10 split on the 22nd of July 2022. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. The company was founded in 2002 and is headquartered in Florham Park, New Jersey. Cellectar Biosc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. For more info on Cellectar Biosciences please contact James Caruso at 608 441 8120 or go to https://www.cellectar.com.

Cellectar Biosciences Investment Alerts

Cellectar Biosciences Upcoming and Recent Events

Cellectar Largest EPS Surprises

View All Earnings Estimates

Cellectar Stock Institutional Investors

Note, although Cellectar Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cellectar Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.18 M.

Cellectar Profitablity

Management Efficiency

Cellectar Biosciences has return on total asset (ROA) of (1.7236) % which means that it has lost $1.7236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (46.9338) %, meaning that it created substantial loss on money invested by shareholders. Cellectar Biosciences' management efficiency ratios could be used to measure how well Cellectar Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of April 6, 2025, Return On Tangible Assets is expected to decline to -1.84. The current year's Return On Capital Employed is expected to grow to -3.06. At present, Cellectar Biosciences' Non Current Assets Total are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.18, whereas Total Assets are forecasted to decline to about 15.8 M.

Technical Drivers

As of the 6th of April, Cellectar Biosciences shows the Mean Deviation of 4.15, standard deviation of 5.3, and Risk Adjusted Performance of 0.002. Cellectar Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cellectar Biosciences Price Movement Analysis

Cellectar Biosciences Insider Trading Activities

Cellectar Biosciences Outstanding Bonds

Cellectar Biosciences Predictive Daily Indicators

Cellectar Biosciences Forecast Models

Cellectar Biosciences' time-series forecasting models are one of many Cellectar Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cellectar Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cellectar Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cellectar shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cellectar Biosciences. By using and applying Cellectar Stock analysis, traders can create a robust methodology for identifying Cellectar entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cellectar analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cellectar analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cellectar Biosciences stock analysis indicators help investors evaluate how Cellectar Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cellectar Biosciences shares will generate the highest return on investment. By understating and applying Cellectar Biosciences stock analysis, traders can identify Cellectar Biosciences position entry and exit signals to maximize returns.

When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.